|Articles|October 18, 2017

Why Should Pharmacists Become More Involved in Veterinary Care?

Veterinary products offer pharmacists a chance to diversify their revenue streams.

In this interview with Pharmacy Times at the National Community Pharmacists Association Annual Convention (NCPA), Jennifer Bruckart, CPHT, of WeCare Pharmacy, in Warrenton, Va. discusses veterinary products as a way for pharmacists to diversify their portfolio and their revenue streams.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Why Should Pharmacists Become More Involved in Veterinary Care?

Newsletter

Related Content

Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events

AI-Powered Digital Twins Offer a New Window Into Tumor Metabolism in Brain Cancer

Financial Assistance Versus Copay Accumulators: Protecting Patients from Cost Shock

FDA Finds No Increased Suicide Risk With GLP-1 Medications, Requests Removal of Warning Labels

Q&A: How Pharmacists Can Help Prevent Missed MMR Vaccinations in Children

Latest CME

Empowering Patients With COPD: The Pharmacist's Role in Personalized Treatment Strategies

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Part 2)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1)

Navigating Diabetes: A Guide to Effective Oral Treatments

Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

The Role of the Pharmacist in the Management of Hyperlipidemia

PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Shaping the Future of Renal Cell Carcinoma: A Case-Based Exploration of Emerging Treatment and Improved Patient Outcomes

Navigating the Complexities of Hormone Receptor–Positive/HER2-Negative Metastatic Breast Cancer in Older Adults: Personalized Treatments for a Vulnerable Population

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

Advancements With CGM Integrations: Insulin Pumps, Connected Pens, and Ketone Monitoring

A Deep Dive Into CGM Data (Pharmacy Technician Credit)

Demystifying CGM: Addressing Frequently Asked Questions and Key Insights

Continuous Glucose Monitoring: What's New in 2025?

Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines

Advances and Innovations in Hypertrophic Cardiomyopathy Management: A Focus on New and Emerging Therapies

Empowering Pharmacists in Travel Medicine: Enhancing Patient Care Through Vaccination, Prevention, and Education

Respiratory Syncytial Virus Disease Prevention in Adults: The Pharmacist’s Role in Improving Vaccine Uptake

Beyond the Prescription: Tackling Social Isolation for Better Health (Pharmacy Technician Credit)

Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases (Pharmacy Technician Credit)

Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases

Empowering Pharmacists in Travel Medicine: Enhancing Patient Care Through Vaccination, Prevention, and Education (Pharmacy Technician Credit)

Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment

Securing the Supply Chain: The Pharmacists’ Role in DSCSA Compliance

Navigating Adverse Effects in HR+/HER2-Negative Metastatic Breast Cancer: Tailored Management Plans and Pharmacist Interventions for Improved Outcomes

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

Addressing Vaccine Hesitancy in Infectious Disease Prevention

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Minimizing Injection Burden: Anti-VEGF Innovation for Retinal Disease Management

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

Managing Overactive Bladder in Older Adults: Challenges and Strategies for Long-Term Care

Bridging Clinical and Access Gaps in Phenylketonuria: A Managed Care Perspective

Enhancing The Role of Oncology Pharmacists in Multidisciplinary Myeloproliferative Neoplasm Care

HER2-Positive Metastatic Breast Cancer: A Managed Care Perspective on Emerging Therapies and Clinical Data

Sugar, We’re Going Down: Navigating Glycemic Control in the Era of PI3K/AKT Inhibition for Breast Cancer

Advancing Patient Safety: Strategies to Address Safety Risks and Adherence Barriers to Optimize Outcomes for Patients on Injectable Therapies

Pharmacogenomics in Practice: Enhancing Patient Care Through Genetic Insights

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations (Pharmacy Technician Credit)

Two Targets, One Mission: Optimizing Bispecific Antibody Use in Non-Hodgkin Lymphoma

Navigating the Complexities of Personalized Prostate Cancer Care: Insights for Oncology Managed Care

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations

Targeting the Complement Cascade: Evolving Strategies in the Management of Complement-Mediated Kidney Diseases

Continuing the Conversation: Pharmacist Interventions to Optimize T2D Care and Break Through Clinical Inertia

Hat Trick for Hypertension: Strategies to Improve Outcomes With Single-Pill Combinations

HER2 in Focus: Biomarker Insights and Therapeutic Advancements Across Solid Tumors

Expanding Access to Antibody-Based Regimens in Relapsed/Refractory Multiple Myeloma

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management